AN
Aluru Narmada
About Aluru Narmada
Data last updated:
Aluru Narmada is a Director at Credo Pharma Private Limited (since 2014), Designated Partner at Virman Critical Care Services Llp (since 2021) and Partner at Auctus Life Sciences Llp (since 2018). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Credo Pharma Private Limited at ₹2.15 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Mar 2014 | 2013 | ₹2.15 Cr (FY 2025) | Active | |
| Designated Partner | 14 Jan 2021 | 2021 | Active | ||
| Partner | 17 Oct 2018 | 2018 | Active |
Board colleagues of Aluru Narmada
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aluru Vamsi Krishna | 06572638 | Credo Pharma Private Limited , Auctus Life Sciences Llp | Director |
| Kandru Madhavarao | 06610196 | Credo Pharma Private Limited | Director |
| Siva Rama Prasad Aluru | 00361671 | Credo Pharma Private Limited , Auctus Life Sciences Llp | Director |
| Maneendra Singarapu | 09030623 | Virman Critical Care Services Llp | Designated Partner |
| Ravi Sankar Vattikuti | 09030624 | Virman Critical Care Services Llp | Designated Partner |
| Vinay Raj Gajula | 08935813 | Virman Critical Care Services Llp | Designated Partner |
| Lakshmi Devi Suryadevara | 06837476 | Auctus Life Sciences Llp | Partner |
| Sreenath Suryadevara | 07234232 | Auctus Life Sciences Llp | Partner |
| Suryadevara Venkateswara Rao | 00363121 | Auctus Life Sciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aluru Narmada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aluru Narmada
Aluru Narmada currently holds 3 directorships: Credo Pharma Private Limited (Director, since 24 Mar 2014, revenue ₹2.15 Cr (FY 2025)); Virman Critical Care Services Llp (Designated Partner, since 14 Jan 2021); Auctus Life Sciences Llp (Partner, since 17 Oct 2018).
Aluru Narmada was first appointed on 24 Mar 2014 as Director at Credo Pharma Private Limited. The most recent appointment on record is 14 Jan 2021 at Virman Critical Care Services Llp.
The current boards of Aluru Narmada's companies include Aluru Vamsi Krishna (Credo Pharma Private Limited), Kandru Madhavarao (Credo Pharma Private Limited), Siva Rama Prasad Aluru (Credo Pharma Private Limited), Maneendra Singarapu (Virman Critical Care Services Llp), Ravi Sankar Vattikuti (Virman Critical Care Services Llp), Vinay Raj Gajula (Virman Critical Care Services Llp), among others.